Key Management Personnel

Dato' Zulkifli Jafar

Managing Director
Age : 52
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position :
• 1 September 2024

Working Experience
Dato' Zulkifli's career began as a legal counsel at Panglima Aces Sdn Bhd in 1997. Rapidly ascending the ranks, he distinguished himself as an advocate and solicitor at Messrs Raslan Loong within the same year and by 2002, Dato' Zulkifli became a partner at Messrs Rashid Zulkifli. Beyond his legal practice, Dato' Zulkifli serves as a director and major shareholder of MMA Resources Sdn Bhd, an oil & gas company.

In addition to his corporate responsibilities, Dato' Zulkifli is actively engaged in shaping the landscape of development and governance. Currently, he holds the positions of Chairman and Director at Era Universe Development Sdn Bhd, a development company.

Dato' Zulkifli had served as the Legal Advisor for Johor State Government Linked Companies (GLC). His diverse portfolio included directorships in esteemed organisations such as the Cooperative Commission of Malaysia, the regulator body of cooperatives in the country; Board of Trustee of the Foundation of Research and Transformation, an independent think tank research body of the Prime Minister’s Office; and Songa Offshore Malaysia Sdn Bhd.

Internationally, Dato' Zulkifli was a director and management member of the Chartridge Conference Centre (UK) Limited, overseeing the operations of four hotels and conference centres in the United Kingdom.

In 2021, Dato' Zulkifli assumed the position of Chairman at Idaman Pharma Manufacturing Sdn Bhd, a subsidiary of Pharmaniaga Berhad (Pharmaniaga) and subsequently, appointed as the Executive Director of Pharmaniaga in March 2022. In February 2023, he was redesignated as Deputy Chief Executive Officer of Pharmaniaga.

On 1 March 2024, Dato' Zulkifli was appointed as the Executive Director of Pharmaniaga, taking over the role and functions of the Executive Committee which was dissolved, and subsequently, he was redesignated as Managing Director on 1 September 2024.

Qualification(s):
• Admission to Malaysian Bar in 1996
• Advocate and Solicitor of the High Court of Malaya
• Certified Patent Agent
• Bachelor of Laws, Universiti Islam Antarabangsa Malaysia

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None.

Any family relationship with any director and/major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None.

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Ahmad Shahredzuan Mohd Shariff

Chief Operating Officer
Age : 42
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position :
• 1 October 2024 (Chief Operating Officer)

Working Experience
Ahmad Shahredzuan began his career at Permodalan Nasional Berhad in 2006. His last position was Senior Manager at the Office of President and Group Chief Executive. Subsequently, he joined McKinsey & Company in 2015 as an Implementation Consultant, where he was involved in the strategy and execution of numerous projects.

In 2019, he expanded his horizon by joining Boustead Holdings Berhad (Boustead) as Senior General Manager. He then rose in the ranks within the Boustead Group to Chief Transformation Officer in May 2020. In March 2021, Ahmad Shahredzuan was appointed as Chief Reinvention and Strategy Officer of Boustead and later redesignated to Group Chief Reinvention and Strategy Officer effective March 2023.

He holds a Bachelor of Economics from the University of Warwick, United Kingdom and obtained his Graduate Diploma of Applied Finance from Kaplan Higher Education in Australia.

On 22 February 2023, he was appointed as Non-Independent Non-Executive Director of Pharmaniaga and later appointed as Chief Operating Officer effective 1 October 2024.

Qualification(s):
• Graduate Diploma of Applied Finance, Kaplan Higher Education, Australia
• Bachelor of Economics, University of Warwick, United Kingdom

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None.

Any family relationship with any director and/major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None.

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Norai’ni Mohamed Ali

Group Chief Financial Officer
Age : 58
Gender : Female
Nationality : Malaysian
Date of Appointment to Present Position : 1 June 2012

Working Experience
Norai’ni is Pharmaniaga’s Group Chief FInancial Officer (CFO) and brings over 31 years of vast working experience in accounting and finance.

Her professional career with the Company spans more than 23 years. She is an accomplished talent who oversees all financial matters, including acquisition of strategic business, treasury, taxation, risk management strategies and formulation of financial policies and tax planning of Pharmaniaga.

Norai’ni joined the Company in 2001 as a Deputy General Manager of Finance. Subsequently, she was appointed as CFO in 2012 and presently sits on the Boards of local and overseas subsidiaries of Pharmaniaga.

Prior to joining the Company, Norai’ni was attached to Opus Group Berhad, a subsidiary of UEM Group Berhad, for eight years. A Chartered Accountant and a fellow member of Association of Chartered Certified Accountant (FCCA), Norai’ni is also a member of the Malaysian Institute of Accountant (MIA) and the ASEAN Chartered Professional Accountants (ASEAN CPA).

Qualification(s):
• Association of Chartered Certified Accountants (ACCA)
• Fellow, Association of Chartered Certified Accountants (FCCA)
• Chartered Accountant, Malaysia Institute of Accountants (MIA)
• ASEAN Chartered Professional Accountants (ASEAN CPA)
• Bachelor of Arts (Honours), Accounting and Finance, Liverpool John Moores University, United Kingdom

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Dr. Badarulhisam Abdul Rahman

Chief Scientific Officer
Age : 57
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position : 1 January 2023

Working Experience
As the Chief Scientific Officer at Pharmaniaga, Dr Badarulhisam spearheads product development and regulatory strategies for the Company, which include product ideation, development, trial, registration, and product life cycle management. He has extensive experience in pharmaceutical and biopharmaceutical manufacturing plant design, construction, equipment and facility qualification & validation and the operation of these plants for the manufacturing of various therapeutic segments and dosage forms including vaccine.

He was also instrumental in establishing Pharmaniaga’s Group-wide sustainability programme, which he headed from 2017 to 2022. He is a qualified Biochemical Engineer with expertise in Biochemical Engineering and Biotechnology.

He completed his Advanced Diploma and Master of Science at University College of London in the United Kingdom. Subsequently, he obtained his PhD from Johns Hopkins University in the United States of America.

Dr. Badarulhisam began his career as a lecturer at the Department of Bioprocess Engineering, Universiti Teknologi Malaysia, where he is still academically active. He then served as an Adjunct Professor at the Chemical Engineering Department of Universiti Putra Malaysia.

Amongst his other accomplishments include his appointment as Board of Academic Advisory of the Faculty of Engineering at Universiti Kebangsaan Malaysia and several other universities. He has also served as an industrial advisor to several Bioprocess Engineering Programmes of major universities in Malaysia and co-supervises masters and PhD students in various aspects of Biopharmaceutical Plant Design, Biologics Drug Development and Process Optimisations.

Qualification(s):
• PhD in Biotechnology, Johns Hopkins University
• MSc in Biochemical Engineering, University College London, United Kingdom
• Advanced Diploma in Biochemical Engineering, University College London, United Kingdom

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None.

Any family relationship with any director and/major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None.

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Wan Intan Idura Wan Ismail

Chief Governance Officer
Age : 45
Gender : Female
Nationality : Malaysian
Date of Appointment to Present Position : 1 August 2024

Working Experience
Wan Intan Idura joined Pharmaniaga in 2010 as an Assistant Manager in the Legal Department and was promoted to Head of the Legal Department in 2012. Her dedication and expertise led to further career advancements within the company, as she expanded her skills and knowledge in corporate governance and legal management.

In 2017, she was promoted to Deputy Director of the Corporate Governance Division and subsequently appointed as Director on 1 July 2021. She has also served as the Company Secretary of Pharmaniaga Berhad since 19 November 2019, overseeing all legal and secretarial functions of the Company.

On 1 August 2024, Wan Intan Idura was appointed as the Chief Governance Officer, a role in which she leads the Legal, Secretarial, Risk Management, and Sustainability functions of Pharmaniaga.

Admitted to the Malaysian Bar in 2006, Wan Intan Idura brings over 18 years of experience as an in-house legal counsel. Her expertise spans both local and international dealings across industries such as pharmaceuticals, information technology solutions, manufacturing, and automotive.

Qualification(s):
• Licensed Company Secretary (LS 0010668)
• Admission to Malaysian Bar in 2006
• Bachelor of Laws (Honours), Universiti Teknologi MARA

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Erick Arjunan Kereshanan

Chief Commercial Officer
Age : 53
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position :
• 2 September 2025

Working Experience
Erick brings with him over 20 years of extensive experience in the pharmaceutical and healthcare industries.

He began his career at Bristol Myers Squibb, where he gained foundational experience in pharmaceutical operations and commercial strategy. His early exposure to global healthcare practices laid the groundwork for his future leadership roles. He later advanced to become Director of Marketing and Sales at Sanofi a position in which he played a pivotal role in driving regional sales performance, expanding market access especially the insulin and Genzyme portfolios, driving new product launches and strengthening market shares across different portfolios and markets.

Over the years, Erick has held senior positions in various reputable organisations such as Novo Nordisk and Merck, consistently delivering results through strategic planning, commercial excellence, business transformation and cross-functional collaboration. His ability to navigate complex market environments and lead high-performing teams has contributed significantly to the success of numerous blockbuster product launches and regional growth initiatives.

Erick holds a Master of Business Administration from Charles Sturt University and a Bachelor of Pharmacy from the University of Manchester.

Qualification(s):
• Master of Business Administration, Charles Sturt University
• Bachelor of Pharmacy, University of Manchester

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None.

Any family relationship with any director and/major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None.

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Mohd Izwan Ishak

Head of Manufacturing
Age : 46
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position : 1 February 2024

Working Experience
Mohd Izwan has been with Pharmaniaga for the past 13 years and held several roles, starting from Head of Production Section up to General Manager of Pharmaniaga Manufacturing Berhad, prior to being appointed as the Acting Head of Manufacturing Operations of the Manufacturing Division effective 1 February 2024.

With over 23 years of experience under his belt in the pharmaceutical industry, he presently leads the four plants located throughout Malaysia. Apart from overseeing superior supply performance and continuous improvement activities of each plant, he led the capacity balancing improvement including the readiness of manufacturing facilities, utilities, equipment and developed organisational capability.

Prior to joining Pharmaniaga, Mohd Izwan was a New Product Development Manager at GlaxoSmithKline (M) Sdn. Bhd.

Mohd Izwan is an active member of various pharmaceutical societies, both locally and internationally, such as the International Society for Pharmaceutical Engineering (ISPE) and a member of the Malaysian Organisation of Pharmaceutical Industries (MOPI).

Qualification(s):
• Bachelor of Accounting (Honours), Universiti Putra Malaysia

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Hairulrizal Samuri

Head of Logistics and Distribution
Age: 47
Gender: Male
Nationality: Malaysian
Date of Appoinment to present position: 21 April 2025

Working Experience
Hairul has over 20 years of experience in supply chain management, procurement, logistics, and distribution, working across various industries such as semiconductors, oil & gas, FMCG, and construction, both in Malaysia and internationally. He began his career in 1999 as an Assistant Manager at Flextronics Technology in Shah Alam, where he gained experience in inventory management, logistics, and operational planning.

In 2007, he transitioned to Emerson Process Management, where he managed the global shipping operations.

In 2011, Hairul took on the role of Regional Logistics Head for ASEAN at Bluescope Steel Asia, where he played a pivotal role in enhancing distribution efficiency and driving significant cost reductions. His ability to streamline operational excellence further expanded when he became the General Manager of Supply Chain at Cement Industries of Malaysia Berhad (CIMA) from 2013 to 2019.

From 2019 to 2023, Hairul moved to Vietnam, where he worked as Head of Logistics at BMT Logistics, responsible for 3PL performance before assumed the role of Global Director at Twinstar Home, overseeing logistics and supply chain operations across ASEAN, China and US.

Before joining Pharmaniaga in 2025, Hairul was the Director of Supply Chain at Omya Malaysia, where he managed the country’s logistics operations and focusing on enhancing operational efficiency.

Throughout his career, Hairul has continuously demonstrated his ability to drive operational excellence, optimise supply chains, and lead diverse teams to achieve business growth. His strategic planning, expertise in procurement, and dedication to cost-effective logistics make him a key player in any supply chain operation.

Qualification(s):
• Master of Business Administration (Strategic Management) from Universiti Teknologi Malaysia
• Bachelor of Business Administration (Honours) in Human Resources from Universiti Teknologi MARA
• Diploma in Banking from Universiti Teknologi MARA

Any directorship in public companies and public listed companies:
None

Any family relationship with any director and/major shareholder of the Company:
None

Any conflict of interests with the Company:
None

Other than traffic offences, any convictions for the past 5 years and other particulars of any public sanction or penalty imposed by the None relevant regulatory bodies during the financial year, if any:
None

Zulhazri Razali

Head of Market Expansion Services
Age : 58
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position : 1 December 2014

Working Experience
Zulhazri joined Pharmaniaga in 1994 as an Assistant Manager of Customer Care, marking the beginning of a remarkable journey within the company. Over the years, he has broadened his expertise across various disciplines, including warehouse management, supply chain, international business, sales and marketing, finance, and business strategy.

In 2014, he was promoted to Commercial Director, where he took charge of the Sales & Marketing Division and played a pivotal role in identifying strategic business opportunities for the Group’s healthcare portfolios within both the private and government sectors in Malaysia.

On 1 December 2024, Zulhazri was redesignated as the Head of Government Business Unit, tasked with overseeing all government-related business functions.

A dynamic leader, Zulhazri excels in articulating strategic goals and plans, ensuring alignment across teams while driving operational efficiency and profitability. His deep understanding of market trends and the competitive landscape positions him as a valuable asset to the organization. He consistently shares these insights with colleagues, contributing to the Company’s and the Group’s long-term growth and success.

Qualification(s):
• Master of Business Administration from University of Manchester, United Kingdom
• Bachelor of Science (Honours), Pharmacy from University of Manchester, United Kingdom

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Dr Imam Fathorrahman

Head of Indonesia Operations
Age : 60
Gender : Male
Nationality : Indonesian
Date of Appointment to Present Position : 2 Janaury 2026

Working Experience
Dr. Imam brings with him a wealth of experience and expertise, supported by a strong educational foundation and decades of professional experience in the pharmaceutical industry.

With a broad expertise spanning marketing and sales strategy, business strategy, retail, pharmaceuticals, business development, and healthcare, he brings a multifaceted skill set to the boardroom, ready to drive strategic initiatives and propel organisational success to new heights.

After earning his Bachelor of Pharmacy degree in 1989, Dr. Imam began his career journey in the pharmaceutical field. Driven by a passion for innovation and strategic foresight, he pursued a Master of Strategic Management to equip himself with the knowledge and skills needed to navigate the complexities of the modern business landscape. Along with the development of science and the challenges of the pharmaceutical industry in the future, Dr. Imam has completed his doctoral programme in Pharmaceutical Sciences at Airlangga University in December 2024.

In 2011 to 2019, he was appointed as President Director of PT Kimia Farma Apotek. Furthermore, Dr. Imam was given a new assignment as Director of Business Development at PT Kimia Farma Tbk in 2019 to strengthen PT Kimia Farma Tbk’s position as a holding company to adapt to new challenges and provide invaluable insights in establishing strategic partnerships and driving sustainable growth initiatives.

Recognised for his outstanding contributions, Dr. Imam held the position of Marketing & Commercial Director from 2021 to 2022, further highlighting his expertise in creating robust marketing and sales strategies to capture the ever-evolving market dynamics.

Throughout his illustrious career, Dr. Imam has played a significant role in winning various awards in the pharmaceutical sector in Indonesia, especially in the field of marketing.

Dr Imam, who previously served as an Independent Non-Executive Director of Pharmaniaga, was appointed as Head of Indonesia Operations effective 2 January 2026.

Qualification(s):
• Doctor of Pharmaceutical Sciences, Airlangga University, Indonesia
• Master of Strategic Management, PPM School of Management, Indonesia
• Bachelor of Pharmacy, Airlangga University, Indonesia

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None

Hayat Al-Mazli Yahaya

Acting Head of Human Capital Management & Administration
Age : 52
Gender : Male
Nationality : Malaysian
Date of Appointment to Present Position : 1 October 2024

Working Experience
Hayat is a highly experienced human resource (HR) practitioner with over 29 years of human resources management in the private sector. He has held various senior roles at Pharmaniaga, overseeing HR strategy, talent development, and employee engagement initiatives.

Before joining Pharmaniaga, Hayat worked at Touch 'n Go Sdn Bhd and TIME Engineering Bhd, where he gained experience in HR management, office administration, and procurement.

Throughout his career, he has successfully led numerous key HR initiatives, focusing on developing high-performance teams and strategically aligning HR practices with corporate objectives for long-term organisational success.

Hayat holds a Master of Social Science in Psychology & Counselling and an Advanced Diploma in Psychology & Counselling from the National University of Malaysia (UKM). Additionally, he earned a Diploma in Business Studies from the University of Wales in collaboration with UNITAR College, Kuala Lumpur.

Qualification(s):
• 2009 - Master of Social Science (Major in Psychology & Counselling), National University of Malaysia (UKM).
• 2005 - Advance Diploma in Psychology & Counselling, National University of Malaysia (UKM).
• 1997 - Certificate of Human Resource Management, University Malaya Kuala Lumpur.
• 1995 - Diploma in Business Studies, University of Wales - UNITAR College, Kuala Lumpur.

Any directorship in public companies and public listed companies:
• None

Directorship in public companies:
• None

Any family relationship with any director and/ major shareholder of the Company:
• None

Any conflict of interests with the Company:
• None

Other than traffic offences, any convictions for offences within the past 5 years and other particulars of any public sanction or penalty imposed by the relevant regulatory bodies during the financial year, if any:
• None